HBOT for Alzheimer's
& dementia.
Roughly 5.8 million Americans live with Alzheimer's today; that number is projected to nearly triple by 2060. There is no cure. Standard medications offer temporary symptom relief. Hyperbaric oxygen is one of the few non-pharmaceutical tools with peer-reviewed evidence for improving cerebral perfusion and supporting cognitive function — used as an adjunct to neurologist-directed care, never in place of it.
A perfusion problem, addressed at the source.
Alzheimer's disease is, at the imaging level, a story of declining cerebral blood flow long before symptoms become severe. Hypometabolic regions on PET scans correspond to the very areas where memory, attention, and executive function live. Standard pharmacology can modulate neurotransmitters; it does not restore perfusion.
HBOT addresses perfusion directly. Pressurized oxygen dissolves into blood plasma at 10–15× normal concentrations and reaches under-perfused brain tissue that red blood cells alone can no longer service. Repeated sessions stimulate angiogenesis (new capillaries), upregulate the endogenous antioxidant system, and lower the neuroinflammatory cytokines tied to amyloid and tau pathology.
It is not a cure. The published trials are careful and the gains are real but bounded. What HBOT offers is a tool with a documented mechanism — for families looking to add something supportive to a treatment plan that otherwise feels limited.
What the research and our clients describe.
Memory, attention, focus
Across the published cognitive-aging literature, multi-session HBOT courses produce measurable gains in memory, attention span, and information-processing speed — particularly in older adults with mild cognitive impairment, where intervention has the highest potential return.
Activities of daily living
Caregivers and clinicians frequently report a return of independence in daily tasks — dressing, conversation, navigation — alongside the more abstract cognitive markers. The functional shift is often what families notice first.
Lowered anxiety, reduced disorientation
Hyperbaric oxygen drives a sustained parasympathetic shift and lowers neuroinflammatory cytokines that contribute to agitation, confusion, and frustration. The behavioral side of dementia often softens before the cognitive markers do.
Cerebral blood flow & amyloid
Imaging studies (PET, SPECT) document increased perfusion to under-active brain regions after HBOT. Animal-model research shows reductions in amyloid plaque burden and neuroinflammation — the two pathological hallmarks of Alzheimer's disease.
Peer-reviewed support.
- — Hadanny et al. — Cognitive enhancement of healthy older adults using HBOT (Aging, 2020)PMID 32589613
- — Shapira et al. — Hyperbaric oxygen therapy ameliorates pathophysiology of 3xTg-AD mouse model by attenuating neuroinflammationPMID 29361403
- — Harch & Fogarty — HBOT for Alzheimer's dementia with PET imaging (case report, Med Gas Res 2018)PMID 30319767
- — Chen et al. — HBOT preserves cognitive function and reduces neuropathology in a rat modelPMID 32218941
- — Shapira et al. — Hyperbaric oxygen therapy alleviates vascular dysfunction and amyloid burden in an Alzheimer's disease mouse modelPMID 34487485
- — Vadas et al. — Hyperbaric oxygen environment can enhance brain activity and multitasking performancePMID 29089872
- — Hu et al. — Hyperbaric oxygen reduces infarction volume and hemorrhagic transformation through ATP/NAD+/Sirt1 pathwayPMID 29089874
Citations link to the original peer-reviewed sources on PubMed.
Before you start.
How early should HBOT be considered?
The strongest published outcomes are in mild cognitive impairment (MCI) and early-to-moderate Alzheimer's, where neural reserve still exists to recruit. Earlier intervention generally produces more durable gains — but supportive benefits have been documented across stages.
Is HBOT safe for older adults?
Yes. HBOT is well tolerated in adults of all ages with appropriate screening. Standard contraindications (untreated pneumothorax, certain ear conditions, specific chemotherapy regimens) apply at every age. We screen every client before starting a protocol.
How long until family members notice a change?
Behavioral changes — calmer demeanor, better sleep, less disorientation — often appear in the first 10–20 sessions. Cognitive gains build across the full 40–60 session course and continue to consolidate for weeks after the protocol ends.
What protocol matches the dementia research?
The 60-session Telomere Protocol™ at 2.0 ATA mirrors the dosing used in the Shamir Medical Center cognitive-aging trials. The 40-session Accelerator is a strong starting course for clients new to HBOT.
Other conditions studied with HBOT.
Anti-aging & cellular renewal
Read the mechanism, the published protocol, and linked PubMed citations.
Addiction & recovery
Read the mechanism, the published protocol, and linked PubMed citations.
Autism spectrum disorder
Read the mechanism, the published protocol, and linked PubMed citations.
A supportive tool, not a substitute.
Our 40- and 60-session protocols match the dosing used in the published cognitive-aging research. Coordinated with your neurologist and care team, never in place of them.
Educational content only. These statements have not been evaluated by the FDA. HBOT is offered as a wellness adjunct, not a substitute for diagnosis or treatment by a licensed professional. Do not modify any prescribed dementia care without consulting your physician.